Compare HZO & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HZO | OCGN |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.7M | 544.3M |
| IPO Year | 1998 | 2014 |
| Metric | HZO | OCGN |
|---|---|---|
| Price | $29.29 | $1.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $30.00 | $9.75 |
| AVG Volume (30 Days) | 240.1K | ★ 5.4M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.58 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,309,288,000.00 | N/A |
| Revenue This Year | $3.67 | N/A |
| Revenue Next Year | $4.01 | $1,718.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.52 | $0.65 |
| 52 Week High | $32.00 | $2.73 |
| Indicator | HZO | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 49.63 |
| Support Level | $24.41 | $1.53 |
| Resistance Level | $31.77 | $1.97 |
| Average True Range (ATR) | 1.51 | 0.10 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 51.75 | 46.15 |
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").